| 301 | PHATPhathom Pharmaceuticals, Inc. |
175,1 M US$ |
-126,3% |
2025 |
| 302 | VALNValneva SE |
174,7 M € |
-66,0% |
2025 |
| 303 | SBCSBC Medical Group Holdings Inc |
173,6 M US$ |
29,4% |
2025 |
| 304 | SNDXSyndax Pharmaceuticals Inc |
172,4 M US$ |
-165,6% |
2025 |
| 305 | RGNXREGENXBIO Inc. |
170,4 M US$ |
-113,8% |
2025 |
| 306 | DNAGinkgo Bioworks Holdings, Inc. |
170,2 M US$ |
-183,8% |
2025 |
| 307 | OGIOrganigram Global Inc. |
159,8 M CAD |
-28,4% |
2024 |
| 308 | MRMDMarimed Inc. |
159,8 M US$ |
-9,1% |
2025 |
| 309 | LQDALiquidia Corp |
158,3 M US$ |
-43,5% |
2025 |
| 310 | HRTXHeron Therapeutics, Inc. |
154,9 M US$ |
-13,0% |
2025 |
| 311 | AIRSAirsculpt Technologies, Inc. |
151,8 M US$ |
-7,7% |
2025 |
| 312 | MGNXMacrogenics Inc |
149,5 M US$ |
-49,9% |
2025 |
| 313 | STIMNeuronetics, Inc. |
149,2 M US$ |
-26,1% |
2025 |
| 314 | ELTPElite Pharmaceuticals Inc |
148,9 M US$ |
30,1% |
2026 |
| 315 | GRALGRAIL, Inc. |
147,2 M US$ |
-277,5% |
2025 |
| 316 | KPTIKaryopharm Therapeutics Inc. |
146,1 M US$ |
-134,2% |
2025 |
| 317 | INFUInfuSystem Holdings, Inc |
143,4 M US$ |
4,6% |
2025 |
| 318 | BEAMBeam Therapeutics Inc. |
139,7 M US$ |
-57,2% |
2025 |
| 319 | NRCNrc Health |
137,4 M US$ |
8,2% |
2025 |
| 320 | RXSTRxSight, Inc. |
134,5 M US$ |
-29,0% |
2025 |
| 321 | AAPGAscentage Pharma Group International |
134,3 M US$ |
-41,3% |
2024 |
| 322 | XTNTXtant Medical Holdings, Inc. |
133,9 M US$ |
3,7% |
2025 |
| 323 | NAIINatural Alternatives International Inc |
129,9 M US$ |
-10,5% |
2025 |
| 324 | NAGENiagen Bioscience, Inc. |
129,4 M US$ |
13,4% |
2025 |
| 325 | LFCRLifecore Biomedical, Inc. DE |
128,9 M US$ |
-30,0% |
2025 |
| 326 | XNCRXencor Inc |
125,6 M US$ |
-73,2% |
2025 |
| 327 | GLUEMonte Rosa Therapeutics, Inc. |
123,7 M US$ |
-31,2% |
2025 |
| 328 | ATRAAtara Biotherapeutics, Inc. |
120,8 M US$ |
27,1% |
2025 |
| 329 | OMOutset Medical, Inc. |
119,5 M US$ |
-68,3% |
2025 |
| 330 | GYREGyre Therapeutics, Inc. |
116,6 M US$ |
8,5% |
2025 |
| 331 | OSUROrasure Technologies Inc |
115 M US$ |
-59,8% |
2025 |
| 332 | AGENAgenus Inc |
114,2 M US$ |
-0,1% |
2025 |
| 333 | IBRXImmunityBio, Inc. |
113,3 M US$ |
-310,2% |
2025 |
| 334 | ANIKAnika Therapeutics, Inc. |
112,8 M US$ |
-9,6% |
2025 |
| 335 | URGNUroGen Pharma Ltd. |
109,8 M US$ |
-139,8% |
2025 |
| 336 | IPSCCentury Therapeutics, Inc. |
109,2 M US$ |
-8,8% |
2025 |
| 337 | MTEXMannatech Inc |
108 M US$ |
-14,1% |
2025 |
| 338 | MDXHMDxHealth SA |
107,9 M US$ |
-31,1% |
2025 |
| 339 | TBPHTheravance Biopharma, Inc. |
107,5 M US$ |
98,5% |
2025 |
| 340 | ZVRAZevra Therapeutics, Inc. |
106,5 M US$ |
78,2% |
2025 |
| 341 | ZYMEZymeworks Inc. |
106 M US$ |
-76,6% |
2025 |
| 342 | SMTISanara MedTech Inc. |
103,1 M US$ |
-36,4% |
2025 |
| 343 | STROSutro Biopharma, Inc. |
102,5 M US$ |
-186,5% |
2025 |
| 344 | BBNXBeta Bionics, Inc. |
100,3 M US$ |
-73,0% |
2025 |
| 345 | NPCENeuroPace Inc |
100 M US$ |
-21,5% |
2025 |
| 346 | BFLYButterfly Network, Inc. |
97,6 M US$ |
-79,0% |
2025 |
| 347 | BLFSBiolife Solutions Inc |
96,2 M US$ |
-4,8% |
2025 |
| 348 | ISPRIspire Technology Inc. |
96 M US$ |
-34,6% |
2026 |
| 349 | KMTSKestra Medical Technologies, Ltd. |
95,1 M US$ |
-138,4% |
2026 |
| 350 | SIGASiga Technologies Inc |
94,6 M US$ |
24,6% |
2025 |